Form 4: Akoya Biosciences CEO Brian McKelligon Reports Stock Transactions
SEC Form 4 Filing
Brian McKelligon, CEO of Akoya Biosciences, reports disposition of shares to cover tax obligations related to restricted stock unit awards.
Summary
- On March 1, 2025, Brian McKelligon, the President and CEO of Akoya Biosciences, Inc., disposed of shares of common stock to cover tax obligations related to previously granted restricted stock unit (RSU) awards.
- 7,550 shares were disposed of at a price of $1.63 to cover taxes on an RSU award granted on February 23, 2023, which vests in four annual installments starting March 1, 2024.
- An additional 8,257 shares were disposed of at a price of $1.63 to cover taxes on an RSU award granted on February 22, 2024, which vests in four annual installments starting March 1, 2025.
- Following these transactions, McKelligon directly owns 427,676 shares of Akoya Biosciences common stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to tax obligations on vested stock, so it's neutral in sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the CEO's transactions related to vested stock awards.
Stakeholder Impact
- The transactions have a minimal impact on shareholders as they are related to tax obligations and do not represent a significant change in ownership.
Key Dates
| Date | Description |
|---|---|
| February 23, 2023 | Date of original restricted stock unit award that vests in four annual installments beginning March 1, 2024. |
| February 22, 2024 | Date of original restricted stock unit award that vests in four annual installments beginning March 1, 2025. |
| March 1, 2024 | First vesting date of the restricted stock unit award granted on February 23, 2023. |
| March 1, 2025 | Date of stock disposal for tax withholding and first vesting date of the restricted stock unit award granted on February 22, 2024. |
| March 4, 2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.